Atlas Trials

Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD

Clinical trial NCT00585910 · COMPLETED

Trial details

NCT number
NCT00585910
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
ADHDAttention Deficit Hyperactivity Disorder
Start date
2004-01-01
Primary completion
2007-12-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.